Trials / Completed
CompletedNCT02604264
Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,912 (actual)
- Sponsor
- Pursuit Vascular, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess positive blood cultures (PBCs) in hemodialysis central venous catheter (CVC) patients using two FDA cleared devices: ClearGuard HD end caps compared to conventional end caps.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ClearGuard HD end cap | The ClearGuard HD End Cap elutes chlorhexidine acetate into the hemodialysis catheter hub |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-11-13
- Last updated
- 2018-09-11
- Results posted
- 2017-05-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02604264. Inclusion in this directory is not an endorsement.